Economic evaluation of rivaroxaban versus enoxaparin for prevention of venous thromboembolism after total knee replacement and total hip replacement: a …

A Rashki Kemmak, A Abutorabi, V Alipour - Clinical Drug Investigation, 2020 - Springer
Background Deep vein thrombosis (DVT) and pulmonary embolism (PE) together are called
venous thromboembolism (VTE) and impose a high economic burden on healthcare …

[HTML][HTML] Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis

F Migliorini, N Maffulli, E Velaj, A Bell… - Journal of Orthopaedics …, 2024 - Springer
Background Several clinical investigations have compared different pharmacologic agents
for the prophylaxis of venous thromboembolism (VTE). However, no consensus has been …

Prophylaxis with rivaroxaban after laparoscopic sleeve gastrectomy could reduce the frequency of portomesenteric venous thrombosis

JI Rodríguez, V Kobus, I Téllez… - The Annals of The …, 2020 - publishing.rcseng.ac.uk
Introduction Portal and mesenteric venous thrombosis is a rare but potentially serious
complication after laparoscopic sleeve gastrectomy. There are no consistent studies that …

The efficacy and cost-effectiveness of enoxaparin versus rivaroxaban in the prevention of venous thromboembolism following total hip or knee arthroplasty: A meta …

J Xu, D Chang, J Chui, J Cao, J Negus - Journal of Orthopaedics, 2022 - Elsevier
Introduction Thromboprophylaxis following total hip and knee arthroplasty is variable across
institutions, but commonly consists of enoxaparin, and more recently rivaroxaban. We aimed …

Sequential low molecular weight heparin and rivaroxaban for venous thromboprophylaxis in pelvic and acetabular trauma

J Crush, M Seah, D Chou, J Rawal, P Hull… - Archives of Orthopaedic …, 2022 - Springer
Introduction Patients with pelvic trauma are at high risk of thromboembolic complications, but
effective methods of prophylaxis are still to be accepted widely. The incidence of venous …

[HTML][HTML] Effective VTE prophylaxis with enoxaparin after elective THR or TKR: a retrospective observational study

DN Catelas, F Cordeiro, L Loureiro… - Porto Biomedical …, 2023 - journals.lww.com
Background: Orthopedic patients are at the highest risk for venous thromboembolism (VTE).
Nowadays, with VTE prophylaxis as a routine in patients undergoing total hip replacement …

[HTML][HTML] Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19: A meta-analysis of randomized controlled trials

X Shen, E Qiu, Z Liu, X Zhu, Y Zeng - Saudi Medical Journal, 2024 - ncbi.nlm.nih.gov
Objectives: To evaluate the effectiveness and safety of rivaroxaban anticoagulation in
COVID-19 patients. Methods: PubMed, Embase, Cochrane Library electronic databases …

Does venous thromboembolism prophylaxis affect the risk of venous thromboembolism and adverse events following primary hip and knee replacement? A …

F Todd, D Yeomans, MR Whitehouse… - Journal of Orthopaedics, 2021 - Elsevier
Background The optimum chemical venous thromboembolism (VTE) prophylactic agents
following total hip and knee replacement (THR and TKR) remain unknown. NICE …

Are vegans being overlooked in our prescribing practices: An orthopaedic perspective from Bristol, United Kingdom

G Silk, N Vetharajan, A Blohm, F Teeling… - Journal of Clinical …, 2023 - Elsevier
Aim Bristol is considered the vegan capital of the UK. The UK vegan index reveals that
Bristol has 360,000 Google searches each month for Vegan content. However, the possible …

[PDF][PDF] Current Evidence and Expert Opinion on Thromboprophylaxis After Total Knee and Hip Replacement

BS Mody, M Wadhwa, R Roy, S Echila Sr - Cureus, 2023 - cureus.com
An effective anticoagulant provides a balance between the risk for venous thromboembolism
(VTE) and bleeding and is crucial in achieving optimal clinical outcomes in patients …